Species-specific effects of the hepatocarcinogens 3'-methyl-4-dimethyl-aminoazobenzene and ortho-aminoazotoluene in mouse and rat liver.
The effects of rat-specific hepatocarcinogen 3'-methyl-4-dimethylaminoazobenzene (3'-MeDAB), mouse-specific hepatocarcinogen ortho-aminoazotoluene (OAT), non-species-specific hepatocarcinogen diethylnitrosamine (DENA), and non-carcinogenic 4'-methyl-4-dimethylaminoazobenzene (4'-MeDAB) on glucocorticoid induction of tyrosine aminotransferase (TAT) and DNA-binding activity of hepatocyte nuclear factor 3 (HNF3) family of transcription factors were investigated with carcinogen-susceptible and -resistant animals. Species-specific hepatocarcinogens 3'-MeDAB and OAT strongly inhibited glucocorticoid induction of TAT in the liver of susceptible but not resistant animals. DENA, which is highly carcinogenic for the liver of both rats and mice inhibited glucocorticoid induction of TAT in both species, while non-carcinogenic 4'-MeDAB was absolutely ineffective both in rats and mice. The inhibition of TAT activity by the carcinogens was due to reduced levels of TAT mRNA, which is most likely to be a result of the reduced rate of transcription initiation of the TAT gene. In all cases, the TAT inhibition was accompanied by significant reduction of DNA-binding activity of the HNF3 transcription factor, which is known to be critical to glucocorticoid regulation of TAT gene. We also demonstrated that the described species-specific effects of OAT and of 3'-MeDAB on HNF3 DNA-binding activity may be initiated not only by administration in vivo, but also by their direct administration to homogenate, intact nuclei or nuclear lysate, but not to nuclear extract fraction, obtained by precipitation with 0.32 g/mL of ammonium sulfate (Fraction I). We showed, that a factor responsible for this effect might be precipitated in 0.32-0.47 g/mL interval of ammonium sulfate concentration. In contrast, non-specific hepatocarcinogen DENA was effective upon being added directly to Fraction I, implying a different mechanism of its action.
Merkulova
Tatyana I
TI
Laboratory of Gene Expression Control, Institute of Cytology and Genetics of the Siberian Division of Russian Academy of Sciences, Novosibirsk, Russia.
Kropachev
Konstantin Y
KY
Timofeeva
Olga A
OA
Vasiliev
Gennady V
GV
Levashova
Zoia B
ZB
Ilnitskaya
Svetlana I
SI
Kobzev
Victor F
VF
Pakharukova
Maria Yu
MY
Bryzgalov
Leonid O
LO
Kaledin
Vasily I
VI
D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D002467:Cell Nucleus / Q000378:metabolism; D004052:Diethylnitrosamine / Q000633:toxicity; D004790:Enzyme Induction; D005938:Glucocorticoids / Q000494:pharmacology; D051541:Hepatocyte Nuclear Factor 3-alpha / Q000096:biosynthesis* / Q000235:genetics; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced* / Q000378:metabolism; D008297:Male; D008749:Methyldimethylaminoazobenzene / Q000633:toxicity*; D051379:Mice; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013045:Species Specificity; D014444:Tyrosine Transaminase / Q000096:biosynthesis* / Q000235:genetics; D009762:o-Aminoazotoluene / Q000633:toxicity*; D004124:p-Dimethylaminoazobenzene / Q000633:toxicity
D002273:Carcinogens; D005938:Glucocorticoids; D051541:Hepatocyte Nuclear Factor 3-alpha; D012333:RNA, Messenger; D004052:Diethylnitrosamine; D008749:Methyldimethylaminoazobenzene; D004124:p-Dimethylaminoazobenzene; D014444:Tyrosine Transaminase; D009762:o-Aminoazotoluene